Steven Shak, Chief Scientific Officer at GENOMIC HEALTH INC (GHDX), sold 71,100 shares at $51.93 ($3.7M) on 2019-06-13, disclosed to the SEC on 2019-06-17.
Seasonal sale ($3.7M) by Chief Scientific Officer — this insider has traded GHDX in June in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $51.93 | 24,191 | $1.3M | 34.1% |
| 2 | $51.93 | 24,191 | $1.3M | 34.1% |
| 3 | $52.43 | 809 | $42K | 1.2% |
| 4 | $52.43 | 809 | $42K | 1.2% |
| 5 | $51.54 | 8,886 | $458K | 12.4% |
| 6 | $51.54 | 8,886 |
| $458K |
| 12.4% |
| 7 | $52.27 | 1,664 | $87K | 2.4% |
| 8 | $52.27 | 1,664 | $87K | 2.4% |
| Total | $51.86 avg | 71,100 | $3.7M | 100% |
| Filing → |
| GHDX | SELL | 2019-08-05 | $3.6M | — | Filing → |
| GHDX | SELL | 2019-07-10 | $2.8M | — | Filing → |
| GHDX | SELL | 2019-06-13 | $5.1M | — | Filing → |